June 2022 "We’re delighted to welcome Dr Ed Brennan as our new Vice President, Head of Clinical Development. Dr Brennan has extensive...

May 2022 "Seoul, South Korea, 28 April 2022 – GPCR therapeutics, Inc., a venture-backed clinical stage international biopharmaceutical...